Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penehyclidine Inhalation for Postoperative Pulmonary Complications
NCT02644876Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Sep 2015
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of penehyclidine in postoperative pulmonary complications (PPC) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of postoperative pulmonary complications at 30 days. Started Sep 2015; status: completed.
02
Drugs
penehyclidine
03
Conditions
postoperative pulmonary complications (PPC)
Beyond the preview
Go deeper on NCT02644876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644876.